Published By : 27 Apr 2016 | Published By : QYRESEARCH
The market for array instruments is gaining significant impetus in the global arena, thanks to the rapidly evolving technologies. Apart from this, the increasing need for early detection of cancer and other chronic disorders has fueled the demand for array instruments significantly. The operational efficiency of these instruments is the key factor behind their increasing popularity.
North America Array Instruments Market to Reach US$526 mn by 2020
Asia Pacific, Latin America, and the Middle East are expected to witness a robust rise in their share in the overall market for array instruments in the coming years. The infrastructural advancement in the medical and healthcare industry and the growing preference for safer targeted therapies are boosting the array instruments markets in these regions.
Investments in Automation Emerge as Latest Trend in Global Array Instruments Market
The global array instruments market is extremely fragmented with a number of established as well as new players operating in it. Illumina Inc., Sigma-Aldrich Corp., Molecular Devices LLC, Bio-Rad Laboratories Inc., ArrayIt Corp., Agilent Technologies Inc., Affymetrix Inc., and Thermo Fisher Scientific are leading this market with a collective share of approximately 80%. Investments in automation are the latest trend among market participants looking for strengthening their positions in the global market.